Back to Nephrology

OUR EXPERTISE AND SERVICES AVAILABLE IN

Kidney Disease

Overview

Spherix’s coverage of the chronic kidney disease market monitors the dynamic and evolving landscape of CKD non-dialysis patient management. We closely track the competitive hyperkalemia market, along with the rapidly evolving diabetic kidney disease market, with specific deep-dives into SGLT2 inhibitors and their potential seismic market impacts. This research also delves into other disease states impacting CKD non-dialysis patients, such as metabolic acidosis and hypertension.

Services Available

Trending market evolution

  • Chronic Kidney Disease (US) - quarterly, n=100

  • Diabetic Kidney Disease, Hyperkalemia, Hypertension, and Metabolic Acidosis

Exploring the patient journey

  • Chronic Kidney Disease, Non-Dialysis (US) - annual, n=1,000 patient charts

  • Dialysis (US) - annual, n=1,000 patient charts

  • Incident Dialysis (US) - annual, n=1,000 patient charts

Learn more about our services

  • HOW CAN WE PARTNER TOGETHER?

    Get more information on Kidney Disease Coverage